MedPath

Comparing of effectiveness carbetocin and oxytocin in reducing bleeding due to child delivery.

Not Applicable
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2022/10/046872
Lead Sponsor
Department of Obstetrics and Gynaecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18 and above

Women in early spontaneous labor

Women planned for cesarean section (ELECTIVE).

.Women undergoing emergency cesarean section in which oxytocin stopped for more than 1hour

Exclusion Criteria

Period of gestation < 28 weeks

Women undergoing labor induction or planned for induction

Underlying cardiovascular, autoimmune, hepatic, or renal disease,

Placenta accreta.

Known allergy to oxytocin or related product.

Patient on anticoagulation.

Patient not in a sound state to give consent(eclampsia, psychiatric disorders) and epilepsy disorder

Instrumental delivery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath